{"hands_on_practices": [{"introduction": "Effective management of postoperative complications begins with rapid and accurate diagnosis. This requires synthesizing fundamental knowledge of anatomy, physiology, and the specific alterations from surgery with the patient's clinical presentation. This exercise challenges you to apply these first principles to a common but life-threatening scenario, helping you to recognize the subtle yet classic signs of an anastomotic leak after a sleeve gastrectomy by connecting referred pain pathways and systemic inflammatory responses to the underlying surgical anatomy [@problem_id:4641624].", "problem": "A patient undergoes laparoscopic sleeve gastrectomy (LSG) creating a narrow tubular stomach by resection along the greater curvature from the antrum to the angle of His, leaving the pylorus intact and producing a relatively high-pressure conduit. On postoperative day $3$, a $42$-year-old woman develops new left shoulder pain that worsens with inspiration, tachycardia at $120$ beats per minute, fever to $38.6^{\\circ}\\mathrm{C}$, and mild hypotension at $98/62$ $\\mathrm{mmHg}$. She reports left upper quadrant discomfort and dyspnea. On examination, there is epigastric and left upper quadrant tenderness without generalized peritonitis, and decreased breath sounds at the left lung base. Laboratory values show a white blood cell count of $17 \\times 10^{9}/\\mathrm{L}$ and a serum lactate of $3.1$ $\\mathrm{mmol}/\\mathrm{L}$. No overt drop in hemoglobin is noted from baseline. Using fundamental principles of referred pain pathways, early postoperative systemic inflammatory response, and the anatomic reconstruction of the sleeve, which postoperative complication is most likely?\n\nA. Proximal staple-line leak near the gastroesophageal junction causing subphrenic contamination with reactive left pleural effusion\n\nB. Acute pulmonary embolism with pulmonary infarction\n\nC. Basilar atelectasis of the left lower lobe\n\nD. Splenic infarction related to short gastric vessel ligation\n\nE. Acute myocardial infarction", "solution": "The reasoning must start from first principles of anatomy and physiology and well-tested clinical observations:\n\n1. Referred pain from diaphragmatic irritation: The phrenic nerve (roots $C3$–$C5$) supplies the diaphragmatic pleura and peritoneum. Irritation of the left hemidiaphragm often produces referred pain to the left shoulder (Kehr sign). Thus, left shoulder pain that worsens with inspiration implies a process irritating the left diaphragm or adjacent structures, such as a subphrenic collection or inflammation.\n\n2. Early postoperative systemic inflammatory response and sepsis indicators: Fever to $38.6^{\\circ}\\mathrm{C}$, tachycardia at $120$ beats per minute, leukocytosis at $17 \\times 10^{9}/\\mathrm{L}$, and lactate at $3.1$ $\\mathrm{mmol}/\\mathrm{L}$ indicate systemic inflammation and probable early sepsis. In the immediate postoperative period after bariatric procedures, common causes include leak with peritoneal contamination, pneumonia, less commonly deep organ abscess by day $3$, or thromboembolic events (which typically do not cause high-grade fever and leukocytosis).\n\n3. Anatomic reconstruction and leak proclivity after laparoscopic sleeve gastrectomy (LSG): LSG creates a high-pressure tubular stomach. The most common site of staple-line failure is the proximal sleeve near the angle of His/gastroesophageal junction. A leak at this location tends to drain or collect in the left subphrenic space, often provoking a reactive left pleural effusion and causing referred left shoulder pain. Timing typically clusters in the first week, often days $2$–$5$.\n\n4. Respiratory findings and laterality: Decreased breath sounds at the left base are consistent with a reactive left pleural effusion or atelectasis secondary to diaphragmatic irritation from a subphrenic process. While atelectasis can cause mild fever early after surgery, it does not typically produce pronounced left shoulder pain or systemic toxicity (elevated lactate) and is most prominent in the first $24$–$48$ hours.\n\nOption-by-option analysis:\n\nA. Proximal staple-line leak near the gastroesophageal junction causing subphrenic contamination with reactive left pleural effusion. This directly aligns with the triad of findings: left shoulder pain from diaphragmatic irritation, early postoperative fever and tachycardia with leukocytosis and elevated lactate indicating sepsis, and decreased left basal breath sounds consistent with reactive effusion. The timing at postoperative day $3$ fits common onset of sleeve leaks. The anatomic reconstruction of the sleeve and high-pressure proximal segment makes this the most likely diagnosis. Correct.\n\nB. Acute pulmonary embolism with pulmonary infarction. Pulmonary embolism can cause tachycardia, dyspnea, pleuritic chest pain, and sometimes low-grade fever. However, prominent left shoulder pain is not typical, high-grade fever and marked leukocytosis are less characteristic early, and the presence of left upper quadrant abdominal tenderness and a classic pattern of left diaphragmatic irritation point away from pulmonary embolism. Oxygen saturation at $94\\%$ on room air is only mildly reduced and nonspecific. Incorrect.\n\nC. Basilar atelectasis of the left lower lobe. Atelectasis is common in the immediate postoperative period and may cause mild fever and decreased breath sounds. However, it typically presents in the first $24$–$48$ hours, does not usually cause severe systemic signs such as elevated lactate, and would not explain referred left shoulder pain or left upper quadrant abdominal tenderness. Incorrect.\n\nD. Splenic infarction related to short gastric vessel ligation. Splenic complications can cause left upper quadrant pain and sometimes left shoulder pain. However, splenic infarct more often presents with persistent left upper quadrant pain and low-grade fever; significant systemic toxicity with elevated lactate early on is less typical unless complications such as abscess or hemorrhage occur. Moreover, no drop in hemoglobin is reported to suggest hemorrhage, and the constellation of left pleural signs with sepsis on day $3$ after LSG more strongly supports a proximal staple-line leak with subphrenic contamination. Incorrect.\n\nE. Acute myocardial infarction. Postoperative myocardial infarction can present with chest pain radiating to the shoulder and tachycardia. However, fever, leukocytosis, left upper quadrant abdominal tenderness, decreased left basal breath sounds, and the inspiratory worsening of shoulder pain are not characteristic. The overall pattern favors an intra-abdominal/infradiaphragmatic inflammatory process. Incorrect.\n\nAdditional management considerations (to reinforce the learning objective on management of early bariatric complications): The immediate approach includes hemodynamic resuscitation, broad-spectrum antibiotics, and nil per os (NPO; nothing by mouth), followed by urgent Computed Tomography (CT; Computed Tomography) of the chest and abdomen with water-soluble oral and intravenous contrast to identify extravasation and collections. Drainage of collections (percutaneous if feasible) and endoscopic interventions (such as stent placement or internal drainage) are commonly employed, with operative intervention reserved for uncontrolled sepsis, failure of less invasive measures, or uncontained leaks.", "answer": "$$\\boxed{A}$$", "id": "4641624"}, {"introduction": "Preventing complications is as crucial as treating them, and venous thromboembolism (VTE) represents a major risk in bariatric surgery patients. Standard dosing regimens for prophylaxis often fail in patients with extreme obesity, leading to a risk of underdosing and treatment failure. This practice problem moves beyond simple weight-based calculations to instill a more rigorous, pharmacologically-sound approach, guiding you through the process of not only calculating an initial dose of enoxaparin but also designing a monitoring plan using anti-Xa levels to ensure therapeutic efficacy [@problem_id:4641531].", "problem": "A $180\\ \\mathrm{kg}$ patient on postoperative day $1$ after Roux-en-Y gastric bypass is at high risk for venous thromboembolism (VTE). The institution’s protocol for Low Molecular Weight Heparin (LMWH) enoxaparin prophylaxis in patients with extreme obesity specifies a weight-based dose of $0.5\\ \\mathrm{mg/kg}$ administered subcutaneously (SC) every $12$ hours. Using the principle that weight-based dosing scales the dose linearly with patient mass, compute the per-administration dose for this patient. Express the final dose per administration in $\\mathrm{mg}$ and round your answer to two significant figures.\n\nIn addition, outline a principled monitoring plan using anti-factor Xa (anti-Xa) activity to avoid underdosing. Your plan should specify the timing of anti-Xa sampling relative to dosing, an appropriate prophylactic target range of anti-Xa activity for bariatric surgery patients, and a dose-adjustment framework grounded in the assumption that, within the prophylactic range, anti-Xa activity is approximately proportional to dose.", "solution": "The problem presents a two-part task: first, to calculate a weight-based drug dose for a patient, and second, to outline a principled monitoring plan for the therapy. The problem is validated as self-contained, scientifically grounded, and well-posed. I will address each part in sequence.\n\n### Part 1: Dose Calculation\n\nThe problem requires the calculation of the per-administration dose of enoxaparin for a patient with a mass, $m$, of $180\\ \\mathrm{kg}$. The institutional protocol specifies a weight-based dose, $d$, of $0.5\\ \\mathrm{mg/kg}$ administered every $12$ hours.\n\nThe total dose, $D$, for a single administration is calculated by scaling the dosing factor linearly with the patient's mass, as stated in the problem statement. The relationship is:\n$$D = m \\times d$$\n\nSubstituting the given values:\n$$D = 180\\ \\mathrm{kg} \\times 0.5\\ \\frac{\\mathrm{mg}}{\\mathrm{kg}}$$\n$$D = 90\\ \\mathrm{mg}$$\n\nThe problem requires the answer to be rounded to two significant figures. The calculated value is exactly $90$. To represent this value with two significant figures unambiguously, we can express it in scientific notation. The digit $9$ is the first significant figure, and the trailing zero must be specified as the second. Therefore, the dose is $9.0 \\times 10^1\\ \\mathrm{mg}$.\n\n### Part 2: Monitoring Plan using Anti-Factor Xa Activity\n\nA principled monitoring plan is required to ensure the adequacy of venous thromboembolism (VTE) prophylaxis and to avoid underdosing, a known concern in patients with extreme obesity. The plan must specify the timing of sample collection, the therapeutic target, and a framework for dose adjustment.\n\n#### 1. Timing of Anti-Xa Sampling\n\nThe activity of Low Molecular Weight Heparin (LMWH) is monitored by measuring its inhibitory effect on Factor Xa, reported as the anti-Factor Xa (anti-Xa) level. To assess the adequacy of a prophylactic dosing regimen administered subcutaneously every $12$ hours (q12h), the peak effect should be measured. For subcutaneously administered enoxaparin, peak plasma concentration and peak anti-Xa activity occur approximately $4$ hours after administration. Therefore, the blood sample for the anti-Xa assay should be drawn $4$ hours after the morning dose of enoxaparin, typically after the third or fourth dose to ensure a steady state has been approached.\n\n#### 2. Prophylactic Target Range of Anti-Xa Activity\n\nFor patients receiving twice-daily (q12h) prophylactic doses of LMWH, the accepted target range for peak anti-Xa activity is:\n$$0.2\\ \\mathrm{IU/mL} \\le \\text{Anti-Xa}_{\\text{peak}} \\le 0.5\\ \\mathrm{IU/mL}$$\nLevels below $0.2\\ \\mathrm{IU/mL}$ may indicate underdosing and insufficient prophylaxis, increasing the risk of VTE. Levels above $0.5\\ \\mathrm{IU/mL}$ for a prophylactic indication suggest excessive anticoagulation, which increases the risk of bleeding complications without offering additional prophylactic benefit. A common practice is to aim for the midpoint of this range, approximately $0.35\\ \\mathrm{IU/mL}$.\n\n#### 3. Dose-Adjustment Framework\n\nThe problem states that anti-Xa activity can be assumed to be approximately proportional to the LMWH dose within the prophylactic range. This provides a clear, quantitative basis for dose adjustment. This linear relationship can be expressed as:\n$$\\text{Anti-Xa Level} = k \\times \\text{Dose}$$\nwhere $k$ is a patient-specific constant of proportionality that reflects the individual's pharmacokinetics and pharmacodynamics.\n\nThis principle can be used to formulate a dose-adjustment rule. Let $D_{\\text{current}}$ be the current dose (e.g., $90\\ \\mathrm{mg}$) and $A_{\\text{measured}}$ be the measured peak anti-Xa level. Let $A_{\\text{target}}$ be the desired anti-Xa level (e.g., $0.35\\ \\mathrm{IU/mL}$). The value of $k$ can be estimated from the patient's current response:\n$$k = \\frac{A_{\\text{measured}}}{D_{\\text{current}}}$$\n\nTo achieve the target anti-Xa level, a new dose, $D_{\\text{new}}$, can be calculated:\n$$D_{\\text{new}} = \\frac{A_{\\text{target}}}{k} = A_{\\text{target}} \\times \\left( \\frac{D_{\\text{current}}}{A_{\\text{measured}}} \\right)$$\nThis provides a simple ratiometric formula for dose adjustment:\n$$D_{\\text{new}} = D_{\\text{current}} \\times \\left( \\frac{A_{\\text{target}}}{A_{\\text{measured}}} \\right)$$\n\n**Framework for Clinical Application:**\n1.  Initiate enoxaparin at the calculated weight-based dose of $90\\ \\mathrm{mg}$ SC every $12$ hours.\n2.  After at least $3$ doses, draw a blood sample $4$ hours after a dose to measure the peak anti-Xa level, $A_{\\text{measured}}$.\n3.  Compare $A_{\\text{measured}}$ to the target range of $0.2 - 0.5\\ \\mathrm{IU/mL}$.\n    *   **If $0.2 \\le A_{\\text{measured}} \\le 0.5\\ \\mathrm{IU/mL}$:** The dose is adequate. No adjustment is needed. Continue the current dose.\n    *   **If $A_{\\text{measured}} < 0.2\\ \\mathrm{IU/mL}$ (underdosing):** The dose must be increased. Calculate the new dose, $D_{\\text{new}}$, using the formula above with a target value $A_{\\text{target}} = 0.35\\ \\mathrm{IU/mL}$. The new dose should be rounded to the nearest clinically available pre-filled syringe size (e.g., $100\\ \\mathrm{mg}$, $120\\ \\mathrm{mg}$).\n    *   **If $A_{\\text{measured}} > 0.5\\ \\mathrm{IU/mL}$ (over-anticoagulation):** The dose should be decreased to reduce bleeding risk. Calculate the new dose, $D_{\\text{new}}$, using the same formula, again aiming for $A_{\\text{target}} = 0.35\\ \\mathrm{IU/mL}$.\n4.  After any dose adjustment, a repeat peak anti-Xa level should be checked after the next $2$-$3$ doses to confirm that the new dose has achieved the desired target activity.", "answer": "$$\\boxed{9.0 \\times 10^1}$$", "id": "4641531"}, {"introduction": "In critical, time-sensitive situations like a suspected anastomotic leak leading to sepsis, patient outcomes are directly linked to the efficiency of the diagnostic and therapeutic response. The Surviving Sepsis Campaign emphasizes a \"bundle\" of interventions to be completed within a short timeframe. This advanced exercise applies principles of operations management and critical path analysis to a clinical workflow, challenging you to identify and sequence tasks to minimize the \"door-to-CT\" time, a key metric in managing surgical sepsis, thereby transforming protocol adherence into an optimized, life-saving process [@problem_id:4641606].", "problem": "A patient who is three days post laparoscopic sleeve gastrectomy presents with tachycardia and left shoulder pain but maintains mean arterial pressure above $65$ millimeters of mercury without vasopressors and normal oxygen saturation. There is a high clinical suspicion for staple-line leak causing early sepsis. Under a Surviving Sepsis Campaign one-hour bundle framework, initial stabilization is prioritized before proceeding to imaging. The institutional protocol states that Computed Tomography (CT) of the abdomen and pelvis with intravenous contrast and oral water-soluble contrast should begin only after broad-spectrum antibiotics are initiated, blood cultures are obtained before the first dose of antibiotics, and oral contrast ingestion is completed. The patient is hemodynamically stable, so vasopressors are not required.\n\nThe following tasks and constraints govern the workflow starting at recognition time $t=0$:\n- Blood cultures ($C$) require $d_{C} = 8$ minutes and must precede antibiotic initiation.\n- Broad-spectrum antibiotics ($A$) are initiated immediately after cultures are completed; the infusion itself lasts $30$ minutes but imaging may proceed while the infusion is running so long as initiation has occurred.\n- Oral contrast ingestion ($O$) requires $d_{O} = 15$ minutes and must begin only after antibiotic initiation.\n- Transport to CT ($T$) requires $d_{T} = 7$ minutes and must occur after oral contrast ingestion is complete.\n- CT scanner setup ($S$) requires $d_{S} = 6$ minutes and must occur after transport is complete.\n- Serum lactate draw and laboratory turnaround ($L$) require a total of $14$ minutes and can occur in parallel with other tasks; completion of $L$ is not a gate for CT initiation.\n- A $1$ liter crystalloid bolus ($F$) runs over $20$ minutes and can occur in parallel with other tasks; completion of $F$ is not a gate for CT initiation.\n\nAssume instantaneous task handoffs when a predecessor completes and unlimited parallelism except where explicit precedence constraints are stated. The institutional policy mandates allocating no more than $60$ minutes to initial stabilization before obtaining CT in a hemodynamically stable patient.\n\nUsing precedence-constrained parallel scheduling from first principles, compute the minimum feasible door-to-CT start time, defined as the earliest time $t$ at which the CT scan can begin under the above constraints. Express your final answer in minutes. No rounding is required.", "solution": "The user has submitted a problem that requires the calculation of the minimum time to begin a Computed Tomography (CT) scan based on a set of tasks with specified durations and precedence constraints. The problem is framed within a clinical context but is fundamentally a scheduling problem that can be solved using critical path analysis.\n\n### Step 1: Extract Givens\nThe problem provides the following data, variables, and constraints, listed verbatim:\n-   Recognition time: $t=0$\n-   **Tasks and Durations:**\n    -   Blood cultures ($C$): $d_{C} = 8$ minutes\n    -   Broad-spectrum antibiotics ($A$): infusion lasts $30$ minutes\n    -   Oral contrast ingestion ($O$): $d_{O} = 15$ minutes\n    -   Transport to CT ($T$): $d_{T} = 7$ minutes\n    -   CT scanner setup ($S$): $d_{S} = 6$ minutes\n    -   Serum lactate draw and lab turnaround ($L$): $d_{L} = 14$ minutes\n    -   $1$ liter crystalloid bolus ($F$): runs over $20$ minutes\n-   **Precedence Constraints and Conditions:**\n    -   Blood cultures ($C$) must precede antibiotic initiation.\n    -   Broad-spectrum antibiotics ($A$) are initiated immediately after cultures are completed.\n    -   Imaging may proceed while the infusion is running so long as initiation has occurred.\n    -   Oral contrast ingestion ($O$) must begin only after antibiotic initiation.\n    -   Transport to CT ($T$) must occur after oral contrast ingestion is complete.\n    -   CT scanner setup ($S$) must occur after transport is complete.\n    -   Serum lactate ($L$) can occur in parallel with other tasks; completion of $L$ is not a gate for CT initiation.\n    -   Crystalloid bolus ($F$) can occur in parallel with other tasks; completion of $F$ is not a gate for CT initiation.\n-   **Objective:**\n    -   Compute the minimum feasible door-to-CT start time, defined as the earliest time $t$ at which the CT scan can begin.\n-   **Policy Constraint (for validation, not calculation):**\n    -   Institutional policy mandates allocating no more than $60$ minutes to initial stabilization before obtaining CT.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is subjected to validation against the established criteria.\n-   **Scientific Grounding:** The problem is a classic scheduling and resource allocation problem, a topic within operations research and applied mathematics. The medical scenario provides a realistic context for the application of these principles but does not introduce any scientific or factual unsoundness. The core task is rigorously mathematical.\n-   **Well-Posed:** The problem is well-posed. It provides a clear objective (find the minimum time), a complete set of tasks with fixed durations, and a clear set of precedence constraints. A unique and meaningful solution can be determined by applying the critical path method.\n-   **Objective:** The problem is stated in precise, quantitative, and unambiguous language. All constraints are explicitly defined.\n-   **Flaw Checklist:**\n    1.  **Scientific/Factual Unsoundness:** None. The problem is logically and mathematically sound.\n    2.  **Non-Formalizable/Irrelevant:** The problem is perfectly formalizable as a directed acyclic graph to find the longest path. It is relevant to the operational aspects of the given medical topic.\n    3.  **Incomplete/Contradictory Setup:** None. All necessary information is provided, and the constraints are consistent.\n    4.  **Unrealistic/Infeasible:** None. The task durations are hypothetical but not physically impossible or inconsistent.\n    5.  **Ill-Posed/Poorly Structured:** None. The objective is clearly stated.\n    6.  **Pseudo-Profound/Trivial:** The problem requires a systematic application of scheduling principles and is not trivial.\n    7.  **Outside Scientific Verifiability:** The solution is verifiable through logical deduction based on the provided constraints.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. A solution will be derived.\n\n### Solution\nThe problem requires finding the minimum time to the start of a CT scan, which is equivalent to finding the length of the critical path in a project schedule. The critical path is the longest sequence of dependent tasks that must be completed to achieve the final objective. The start of the CT scan is the final event.\n\nLet $t_{start}(X)$ and $t_{end}(X)$ represent the start and end times of a task $X$, respectively. The duration of task $X$ is denoted by $d_X$. The project begins at $t=0$. The end time of a task is given by $t_{end}(X) = t_{start}(X) + d_X$. We seek the minimum value of $t_{start}(CT)$.\n\nThe tasks that are not gating factors for the CT scan are the serum lactate draw ($L$) and the fluid bolus ($F$), as they can occur in parallel and their completion is not a prerequisite. The antibiotic infusion time is also explicitly stated not to be a gate. We will analyze the sequence of tasks that form the main dependency chain leading to the CT scan.\n\n1.  **Blood Cultures ($C$):** This is the first task in the sequence. It starts at $t=0$.\n    -   $d_C = 8$ minutes.\n    -   $t_{start}(C) = 0$.\n    -   $t_{end}(C) = t_{start}(C) + d_C = 0 + 8 = 8$ minutes.\n\n2.  **Antibiotic Initiation ($A$):** This task must start immediately after the blood cultures are completed.\n    -   $t_{start}(A) = t_{end}(C) = 8$ minutes.\n    -   The problem states that only the *initiation* of antibiotics is required for subsequent steps, not the completion of the $30$-minute infusion. Thus, the infusion duration does not lie on the critical path.\n\n3.  **Oral Contrast Ingestion ($O$):** This task can begin only after the antibiotic initiation. To minimize the total time, it should start as soon as its prerequisite is met.\n    -   $d_O = 15$ minutes.\n    -   $t_{start}(O) \\ge t_{start}(A)$.\n    -   Minimum $t_{start}(O) = t_{start}(A) = 8$ minutes.\n    -   $t_{end}(O) = t_{start}(O) + d_O = 8 + 15 = 23$ minutes.\n\n4.  **Transport to CT ($T$):** This task must occur after oral contrast ingestion is complete.\n    -   $d_T = 7$ minutes.\n    -   $t_{start}(T) \\ge t_{end}(O)$.\n    -   Minimum $t_{start}(T) = t_{end}(O) = 23$ minutes.\n    -   $t_{end}(T) = t_{start}(T) + d_T = 23 + 7 = 30$ minutes.\n\n5.  **CT Scanner Setup ($S$):** This task must occur after the patient transport is complete.\n    -   $d_S = 6$ minutes.\n    -   $t_{start}(S) \\ge t_{end}(T)$.\n    -   Minimum $t_{start}(S) = t_{end}(T) = 30$ minutes.\n    -   $t_{end}(S) = t_{start}(S) + d_S = 30 + 6 = 36$ minutes.\n\nThe CT scan can begin only after the scanner setup is complete. Therefore, the earliest possible start time for the CT scan is the completion time of task $S$.\n-   $t_{start}(CT) \\ge t_{end}(S)$.\n-   Minimum $t_{start}(CT) = t_{end}(S) = 36$ minutes.\n\nThe critical path is the sequence of tasks $C \\rightarrow A_{initiation} \\rightarrow O \\rightarrow T \\rightarrow S$. The total duration is determined by the sum of durations of tasks that must be performed sequentially.\n-   Time for $C$: $8$ minutes.\n-   At $t=8$, $A$ is initiated and $O$ begins.\n-   Time for $O$: $15$ minutes. This task finishes at $t = 8 + 15 = 23$ minutes.\n-   Time for $T$: $7$ minutes. This task begins at $t=23$ and finishes at $t = 23 + 7 = 30$ minutes.\n-   Time for $S$: $6$ minutes. This task begins at $t=30$ and finishes at $t = 30 + 6 = 36$ minutes.\n\nThe CT scan can begin at $t=36$ minutes.\n\nThe parallel tasks $L$ (duration $14$ minutes) and $F$ (duration $20$ minutes) can start at $t=0$ and will be completed at $t=14$ and $t=20$, respectively. Since both of these times are less than $36$ minutes, these tasks do not delay the start of the CT scan and are not part of the critical path. The calculated time of $36$ minutes is within the institutional policy limit of $60$ minutes.", "answer": "$$\\boxed{36}$$", "id": "4641606"}]}